Abstract
Objective
This meta-analysis aimed to evaluate the effects of manual therapy (MT) on cancer pain, so as to provide clinical evidence for application.
Methods
Five English and Chinese databases were searched until February 29, 2020, for randomized controlled trials (RCTs) of MT for cancer pain. Articles published in the English or Chinese language were included. Two authors independently reviewed all articles and extracted the data, and any disagreements in the above process were discussed with other reviewers until the authors reached consensus. Review Manager 5.3 was used to calculate the effect size and 95% confidence intervals. This review was registered in PROSPERO, number CRD42020172053.
Results
The intensity of cancer pain is our primary outcome measure, and compared with standard care, MT can significantly relieve the pain of patients with cancer (SMD, 0.63; 95% CI [0.18, 1.08]; P=0.006 < 0.01); the effects of MT plus active activity were significantly different from AT alone (SMD, 0.79; 95% CI [0.28, 1.30]; P=0.002 < 0.01); there was no statistical difference in the efficacy of MT and AT alone (SMD, -0.24; 95% CI [-1.09, 0.62]; P=0.53 > 0.05). In other related symptoms, the above evidence cannot support that MT had a good effect on fatigue (SMD, 0.77; 95% CI [-0.09, 1.63]; P=0.08 > 0.05), nausea (SMD, 0.24; 95% CI [-0.00, 0.48]; P=0.05), anxiety (SMD, 0.76; 95 % CI [-0.32, 1.84]; P=0.17 > 0.05), and depression (SMD, 0.67; 95 % CI [-0.28, 1.62]; P=0.17 > 0.05); however, MT intervention can improve physical function (n = 271; SMD, 0.35; 95 % CI [-0.04, 0.74]; P=0.04 < 0.05) and global well-being (SMD, 0.50; 95 % CI [0.02, 0.98]; P=0.04 < 0.05). In addition, MT had a significant effect on pain relief (SMD, 0.52; 95% CI [0.03, 1.01]; P=0.04 < 0.05) and improvement of physical function (SMD, 0.28; 95% CI [0.02, 0.53]; P=0.03 < 0.05) even after a period of time after treatment.
Conclusion
MT was an effective intervention, which may have immediate effect on cancer pain and may improve physical function and global well-being. In the view of follow-up effects, MT had good effects for the reduction of pain and the recovery of physical function. However, because of limitations, the seemingly promising results should be interpreted with caution.
1. Introduction
With the rapid development of modern medicine, the cure rate of many diseases has increased considerably, but tumor is still the main killer affecting human health [1]. Constantly updated anticancer methods and pharmacologic agents significantly increased the survival rate of patients with malignant tumors, but their quality of life (QoL) was not obviously improved [2]. Continuous pain not only affects the physical health of cancer patients but also leads to severe anxiety, depression, insomnia, fatigue, and other symptoms [3]. Though the three-step analgesic ladder for managing cancer pain provided by the World Health Organization has been widely used in clinical practice [4], insufficient ability of pain assessment [5, 6], adverse reactions of analgesic drugs, and rising health costs make government organizations have to seek nonpharmacologic treatment [7]. In the 2019 version of adult cancer pain guidelines [8], the National Comprehensive Cancer Network (NCCN) has integrated a large number of nonpharmacologic therapies for cancer pain including massage, acupressure, acupuncture, psychological support, and exercise.
Manual therapy (MT), as complementary and alternative therapy, is skilled hand manipulations, including massage, chiropractic, osteopathic medicine, and others. MT was widely applied in many countries intended to improve soft tissue movement restriction, relieve pain, and promoting psychological well-being. Several studies reported that MT showed beneficial improvements in cancer-related pain and emotional problems [9, 10]. However, some reviews indicated that there was insufficient evidence on the effect of MT in relieving cancer pain [11]. The effects of MT for cancer pain and related symptoms are controversial.
In the past decade, many cancer sufferers used MT as a complementary therapy, to not only relieve pain but also promote psychological well-being [12]. And some high-quality randomized controlled trials (RCTs) were published [13–15], which paid more attention to the follow-up effects of MT for cancer patients. In China, MT, named Tuina, was widely applied to relieving pain in patients [16, 17], but the related studies did not get sufficient attentions in the previous reviews. In this study, more rigorous RCTs published in recent years and Chinese studies were included.
The current systematic review was aimed to examine the evidence on the effect of MT for cancer pain and related psychological well-being. The following questions are focused: (1) the effectiveness of MT in relieving cancer pain compared with standard care or other nonpharmacologic treatments; (2) the effects of MT in promoting psychological well-being by improving depression, anxiety, nausea, and others; (3) the follow-up effects of MT after the final treatment.
2. Methods
This study followed the guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). This review was registered in PROSPERO (registration number: CRD42020172053).
2.1. Search Strategy
Five databases and reference lists were searched for RCTs published until February 29, 2020. English databases included PubMed and EMBASE, and Chinese databases included China National Knowledge Infrastructure, VIP Database for Chinese Technical Periodicals, and Wanfang Data. The search strategy consisted of four components: disease diagnosis (“neoplasia” OR “tumor” OR “cancer” OR “malignancy” OR “carcinoma”), clinical condition (“pain” OR “analgesia” OR “symptom relief”), intervention method (“massage” OR “Tuina” OR “zone therapy” OR “reflexology” OR “Rolfing” OR “bodywork” OR “manipulation” OR “chiropractic” OR “osteopathic” OR “physical therapy” OR “motion therapy”), and study type (randomized clinical trial). Appropriate keywords from MeSH headings were used in combination to develop searches by titles or abstracts to establish the eligibility of the studies. In addition, reference lists from all relevant articles were reviewed to make sure no RCTs were missed.
2.2. Study Selection
Two authors (C. Y. and L. K.) independently reviewed all articles by titles and abstracts, or full text if necessary, to evaluate their eligibility for inclusion. Articles published in the English or Chinese language were included if they were RCTs (excluding crossover design) investigating the association of MT with cancer pain. Patients with various types (breast cancer, lung cancer, colon cancer, etc.) of cancers were included without any restrictions on the age, gender, race, clinical status, and duration of cancer, but the baseline data must show no significant statistical difference between the experiment group (EG) and control group (CG) in each independent RCT. Eligible EG interventions were any technique of MT, including massage, osteotomy, chiropractic, acupressure, reflexology, trigger point therapy, and other physical therapies operated only by hands, compared to placebo, standard care, and any active treatments not related to MT as the CG. In addition, cancer pain in this article included pain directly caused by the development of cancer, chronic pain associated with cancer treatment, and acute pain after surgery.
The primary outcome of interest was pain, which can be measured by the Numerical Rating Scale (NRS), the Visual Analog Scale (VAS), the Brief Pain Inventory (BPI), and any other validated instrument. The secondary outcomes were QoL, functional improvement, negative emotions, and other cancer-related symptoms, for which no restriction set on the type of tool used in the studies as there were no universally accepted tools available. These symptoms had clear diagnostic criteria in related RCTs and were assessed by different scales, such as Short Form-36 questionnaire (SF-36), Functional Assessment of Cancer Therapy-Breast (FACT-B), Brief Fatigue Inventory (BFI), and others.
Studies were excluded if any of the following were identified: (1) the study only reported improvement rates and no other specific data to refer to; (2) the use of MT was not the single variable between intervention of the EG and CG, because other factors in the experiment may affect the results (e.g., music and acupuncture); (3) the intervention of CG contained MT, because the effects of MT could not be assessed; (4) the language of articles was neither English nor Chinese.
2.3. Data Abstraction and Methodological Quality Assessment
All the data were independently extracted by two reviewers (C. Y. and L. K.) in the mentioned databases according to predefined criteria, including first author, country of the study, year of the study, clinical situation, sample size, mean age of participants, duration of treatments, follow-up time, interventions of the EG and CG, outcome measures, and results. However, some less frequent outcome measures were not analyzed to better integrate the data (n < 3). Studies were excluded if they did not provide complete data needed to calculate the effect size. If there were multiple assessment time points, the time point of the last postintervention was chosen. To ensure rigor in the data abstraction process, the two reviewers also independently checked all the records to minimize bias.
All RCTs included in the study were assessed independently by two reviewers according to the physiotherapy evidence database (PEDro) scale, which is reported to have excellent reliability for RCTs of the physiotherapy [18]. The risk of bias of each study was assessed through the generation of a score, which was calculated by 11 items in the PEDro scale. Each item is scored as either 1 or 0 according to whether the item is met or not. However, the first item is not used to calculate the final score, so the total score ranges from 0 to 10. A higher score indicates better methodological quality, but it has been reported a score of at least 6 is considered a high-quality study [19]. We contacted the study authors if more information is needed, and any disagreements in the above process were discussed with another reviewer (Y. C.) until the authors reached consensus.
2.4. Data Synthesis and Statistical Analysis
The meta-analysis was performed by calculating the effect size and 95% confidence intervals (CI) in the Review Manager 5.3. To assess the effects of MT on each outcome measure in the meta-analyses, we used the mean changes in outcomes between the end of final intervention and the baseline, which showed the difference between the EG and CG. The standardized mean difference (SMD) was used because different scales were applied to evaluate the outcomes, including NRS, VAS, and BPI. For studies with more than one CG, the results were split into comparisons between the EG and each CG. Statistical heterogeneity was assessed using I2, and the value of which more than 50% was determined as a high level of heterogeneity. If I2 < 50% in the results, we used a fixed effect model, otherwise a random effects model was used. A funnel plot was used to analyze bias.
3. Results
1662 records were searched from 5 databases, and reference lists were included. After removing duplicates and screening eligibility by title and abstract, fifty-one articles were included to be fully assessed. Thirty-four studies were excluded because they did not meet the inclusion criteria, and we selected 17 eligible articles. In the process of exclusion, the studies were excluded due to inappropriate intervention (n = 2) [20, 21], insufficient data (n = 1) [22], and inappropriate control method (n = 1) [23]. In the end, a total of 13 studies were included in our meta-analysis, including 11 English articles and 2 Chinese. The study selection process is summarized in Figure 1.
Figure 1.
Study selection process.
3.1. Study Characteristics
A total of 13 eligible studies, ranging from 2000 to 2019, evaluated the effects of MT on cancer pain. Eleven hundred participants, including 556 in the EG and 544 in the CG, with the mean age of 55.23, were conducted, respectively, in the USA, Germany, Italy, the UK, China, and other countries. Six studies focused on a specific kind of cancer (5 breast cancer [13–15, 24, 25] and 1 gastric or liver cancer [26]), and the remaining 7 RCTs involved any type of cancer in any stage [27–33].
Two studies [26, 33] observed the short-term effects of MT on cancer pain, and the treatment duration was 2 days and 3 days, respectively, so no follow-up was conducted. The other 11 studies [13–15, 24, 25, 27–32] lasted from 2 weeks to 3 months, 5 [13–15, 25, 29] of which involved follow-up for 6 weeks to 3 months. One study [29] claimed that the results of follow-up would be reported separately, but we did not find them. Of the 13 RCTs, one study [33] only observed cancer pain and other studies involved cancer-related side effects such as anxiety, depression, and fatigue.
MT in the studies mainly included massage therapy [15, 25, 27–29, 32], myofascial therapy [14, 24, 30], foot reflexology [13, 26], osteopathic manipulative treatment [31], and acupressure [33]. The control therapies contained standard care [13, 15, 26, 27, 30, 32, 33] and active therapies (AT) including physical therapy [14, 31], kinesiotherapy [24, 25], reading therapy [29], and psychological support [28]. The frequency of intervention was from twice a day to once a week, and each intervention method lasted from 10 to 50 minutes. When assessing the effects of MT, seven studies [13, 15, 26, 27, 30, 32, 33] compared the efficacy differences between MT and standard care. In addition, four studies [14, 24, 25, 31] compared MT plus AT and AT alone, and two studies [28, 29] compared MT with AT. The details of all studies are summarized in Tables 1 and 2.
Table 1.
Characteristics of studies of manual therapy on cancer pain.
| First author, year, country | Clinical situation | Sample size | Mean age (year) | Duration | Followup | Outcome measures | ||
|---|---|---|---|---|---|---|---|---|
| De Groef, 2017, Belgium [14] | Breast cancer (postoperation) | EG: 25 | EG: 55.3 | Primary | Pain (VAS↓) | |||
| 3 months | 3 months | Physical function | ||||||
| Secondary | QoL (SF-36↑) | |||||||
| CG: 25 | CG: 53.1 | Mental function | ||||||
|
| ||||||||
| Listing, 2009, Germany [15] | Breast cancer (I-II, postoperation) | EG: 50 | EG: 57.6 | Primary | Pain (SF-8↑) | |||
| 5 weeks | 6 weeks | Breast symptoms | ||||||
| Secondary | QoL (EORTC QLQ-BR23↓) | |||||||
| CG: 36 | CG: 61.4 | Arm symptoms | ||||||
|
| ||||||||
| Rangon, 2017, Brazil [24] | Breast cancer (postoperation) | EG: 10 | EG: 55.4 | Primary | ||||
| 5 weeks | No follow-up | Pain (NRS↓) | ||||||
| CG: 10 | CG: 54.4 | Secondary | QoL (FACT-B↑) | |||||
| QoL (FACT-B↑) | ||||||||
|
| ||||||||
| Wyatt, 2012, USA [13] | Breast cancer (III-IV, or I-II with metastasis or recurrence) | EG: 95 | EG: 55.3 | Primary | ||||
| Physical function (SF-36↑) | ||||||||
| 5 weeks | 6 weeks | Pain (BPI↓) | ||||||
| CG: 96 | CG: 57.3 | Secondary | Fatigue (BFI↓) | |||||
| Depression (CES-D↓) | ||||||||
|
| ||||||||
| Tsay, 2008, Taiwan [26] | Gastric or liver cancer (postoperation within 24 hours) | EG: 30 | Primary | Pain (VAS↓) | ||||
| 59.8 ± 14.7 | 3 days | No follow-up | ||||||
| CG: 30 | Secondary | Anxiety (HADS↓) | ||||||
|
| ||||||||
| Beurskens, 2007, Netherlands [25] | Breast cancer (postoperation) | EG: 15 | EG: 53.7 | Primary | Pain (VAS↓) | |||
| 3 months | 3 months | Physical function (DASH↓) | ||||||
| CG: 15 | CG: 55.4 | Secondary | ||||||
| QoL (SIP↓) | ||||||||
|
| ||||||||
| Wilkie, 2000, USA [27] | Any type of cancers (advanced) | EG: 15 | Primary | Pain (VAS↓) | ||||
| 64 | 2 weeks | No follow-up | ||||||
| CG: 14 | Secondary | QoL (Graham's QoL↑) | Global well-being | |||||
| Primary | Anxiety (SAI↓) | |||||||
|
| ||||||||
| Wilkinson, 2007, UK [28] | Any type of cancers (any stage) | EG: 144 | EG: 51.5 | Depression (CES-D↓) | ||||
| Pain | ||||||||
| 10 weeks | No follow-up | |||||||
| Fatigue | ||||||||
| Secondary | QoL (EORTC QLQ-C30↓) | |||||||
| CG: 144 | CG: 52.8 | Nausea | ||||||
| Global well-being | ||||||||
|
| ||||||||
| Collinge, 2013, USA [29] | Any type of cancers (any stage) | Primary | Anxiety (NRS↓) | |||||
| EG: 47 | 54.7 | 4 weeks | 16 weeks | |||||
| Secondary | QoL (NRS↓) | Pain | ||||||
| CG: 50 | Fatigue | |||||||
| Depression | ||||||||
| Nausea | ||||||||
|
| ||||||||
| Pyszora, 2017, Poland [30] | Any type of cancers (advanced) | Primary | Fatigue (BFI↓) | Pain | ||||
| EG: 30 | EG: 72.4 | 2 weeks | No follow-up | Nausea | ||||
| Secondary | Symptoms (ESAS↓) | Depression | ||||||
| CG: 30 | CG: 69.3 | Anxiety | ||||||
| Global well-being | ||||||||
|
| ||||||||
| Arienti, 2018, Italy [31] | Any type of cancers (postoperation) | Primary | Pain (NRS↓) | |||||
| EG: 12 | EG: 76.5 | |||||||
| 4 weeks | No follow-up | Global well-being | ||||||
| Secondary | QoL (EORTC QLQ-C30↓) | Financial difficulties | ||||||
| CG: 11 | CG: 76.5 | Summary score | ||||||
|
| ||||||||
| Qian, 2018, China [32] | Any type of cancers (advanced) | EG: 68 | EG: 43.7 | 2 weeks | No follow-up | Primary | Pain (NRS↓) | |
| Anxiety (SAS↓) | ||||||||
| Secondary | ||||||||
| CG: 68 | CG: 45.1 | |||||||
| Depression (SDS↓) | ||||||||
|
| ||||||||
| Chen, 2019, China [33] | Any type of cancers (advanced) | EG: 15 | EG: 55.3 | Pain (NRS↓) | ||||
| 2 days | No follow-up | Primary | ||||||
| CG: 15 | CG: 54.2 | |||||||
EG: experiment group; CG: control group; VAS: Visual Analog Scale; QoL: quality of life; SF-36 : Short Form-36 Questionnaire; SF-8 : Short Form-8 Health Survey; EORTC QLQ: European Organization of Research and Treatment of Cancer QoL Questionnaire; NRS: Numerical Rating Scale; FACT-B: Functional Assessment of Cancer Therapy-Breast; BPI: Brief Pain Inventory; BFI: Brief Fatigue Inventory; CES-D: Center of Epidemiologic Studies-Depression Scale; HADS: Hospital Anxiety and Depression Scale; DASH: Disability of the Arm, Shoulder, and Hand Questionnaire; SIP: Sickness Impact Profile; SAI: State Anxiety Inventory; ESAS: Edmonton Symptom Assessment Scale; SAS: Self-Rating Anxiety Scale; SDS: Self-Rating Depression Scale. “↑” indicates that the higher the score was, the better the symptoms, and “↓” indicates that the lower the score was, the better the symptoms.
Table 2.
Intervention process of studies of manual therapy on cancer pain.
| First author, year, country | Intervention EG | Procedure EG | Intervention CG | Procedure CG |
|---|---|---|---|---|
| De Groef, 2017, Belgium [14] | 18 sessions of a standard physical therapy program of 30 min (week 1–8 twice a week, week 9–12 once a week). 12 sessions of myofascial therapy of 30 min (once a week) | Physical therapy: shoulder mobilization; pectoral muscle stretching; exercise therapy. Myofascial therapy: myofascial release on active myofascial trigger points at the upper body, on myofascial adhesions in the pectoral, axilla, cervical region, diaphragm, and scars | 18 sessions of a standard physical therapy program of 30 min (week 1–8 twice a week, week 9–12 once a week). 12 sessions of placebo treatment of 30 min (once a week) | Physical therapy: shoulder mobilization; pectoral muscle stretching; exercise therapy. Placebo: placements of hands up and down the upper body and arm on the affected side and lasted for 10–15 sec at one location |
|
| ||||
| Listing, 2009, Germany [15] | 10 sessions of classical massage of 30 min (twice a week) | Classical massage: massage of the back, neck, and head, consisted of Swedish techniques such as stroking, kneading, frictions, pressing on the trigger points, stretching the neck and the lumbar spine area, and depressing the shoulders and the hip area | Medical routine | No intervention, standard care |
|
| ||||
| Rangon, 2017, Brazil [24] | 10 sessions of kinesiotherapy of 50 min (twice a week). 10 sessions of ischemic compression of 90 sec (twice a week) | Kinesiotherapy: walk; neck active stretching, anterior and posterior chain of higher trunk; active mobilization of the cervical spine, upper limbs; relaxation exercises. Ischemic compression: pressing bilaterally on the myofascial trigger point centrally located in the upper trapezius muscle | 10 sessions of kinesiotherapy of 50 min (twice a week) | Kinesiotherapy: walk; neck active stretching, anterior and posterior chain of higher trunk; active mobilization of the cervical spine, upper limbs; relaxation exercises |
|
| ||||
| Wyatt, 2012, USA [13] | 20 sessions of foot reflexology of 30 min (4 times a week) | Foot reflexology: stimulation of the nine essential breast cancer-specific reflexes with reflexology-specific deep thumb-walking pressure | Medical routine | No intervention, standard care |
|
| ||||
| Tsay, 2008, Taiwan [26] | 3 sessions of foot reflexotherapy of 20 min (once a day) | Foot reflexology: massage of digestive reflex zones of upper and lower abdomen, liver, spleen, gall bladder, duodenal, intestine, and colon | Medical routine | No intervention, standard care |
|
| ||||
| Beurskens, 2007, Netherlands [25] | 9 sessions of physiotherapy (once or twice a week for the first 3 weeks, and thereafter once a fortnight or less). 90 sessions of home exercises of 10 min (once a day) | Physiotherapy: soft tissue massage of the surgical scar; exercise for arm/shoulder, muscular strength, coordination, and improvement of general physical condition. Home exercises: exercises for the arm/shoulder | 90 sessions of home exercises of 10 min (once a day) | Home exercises: exercises for the arm/shoulder |
|
| ||||
| Wilkie, 2000, USA [27] | 4 sessions of massage therapy of 30–45 min (twice a week) | Massage therapy: massage of head/back/gluteus muscles/four extremities, including effleurage, light petrissage, naive stroke, light compression, vibration, and tapotement | Medical routine | No intervention, standard care |
|
| ||||
| Wilkinson, 2007, UK [28] | 40 sessions of aromatherapy massage of 60 min (4 times a week) | Aromatherapy massage: massage with essential oils, massage strokes, timings, and overall style | Usual supportive care | Usual supportive care: psychological support services |
|
| ||||
| Collinge, 2013, USA [29] | 12 sessions of massage therapy of 20 min (3 times a week) | Massage therapy: manual techniques for comfort and relaxation of head/neck/shoulders/back/feet/hands, including touching and acupressure | 12 sessions of reading therapy of 20 min (3 times a week) | Reading therapy: reading any literature such as poetry, fiction, nonfiction, and religious |
|
| ||||
| Pyszora, 2017, Poland [30] | 6 sessions of physiotherapy programme of 30 min (3 times a week) | Physiotherapy programme: techniques of myofascial release and proprioceptive neuromuscular facilitation | Medical routine | No intervention, standard care |
|
| ||||
| Arienti, 2018, Italy [31] | 4 sessions of osteopathic manipulative treatment of 45 min (once a week). 28 sessions of physiotherapy of 30 min (once a day) | Osteopathic manipulative treatment: dorsal/lumbar soft tissue/rib raising; back/abdominal myofascial release; cervical spine soft tissue/suboccipital decompression; sacroiliac myofascial release; strain-counterstain; and muscle energy technique. Physiotherapy: passive mobilization, active exercises, and walk | 28 sessions of physiotherapy of 30 min (once a day) | Physiotherapy: passive mobilization, active exercises, and walk |
|
| ||||
| Qian, 2018, China [32] | 28 sessions of massage therapy of 10 min (twice a day) | Massage therapy: pressing and rubbing with oils on Baihui (DU20)/Shenmen (HT7) and other acupoints related to symptoms | Medical routine | No intervention, standard care |
|
| ||||
| Chen, 2019, China [33] | 28 sessions of acupressure of 20 min (twice a day) | Acupressure: pressing on Neiguan (PC6) and Zusanli (ST36) | Medical routine | No intervention, standard care |
EG: experiment group; CG: control group.
3.2. Methodological Quality
The methodological quality of the studies was accessed in Table 3. According to the PEDro scale, all the studies received a score of 6 or more, indicating they were considered to be of high quality. However, five studies [15, 27, 31–33] were at the limit of the cutoff with scores of 6, and the reason for which was that although random assignment of patients was adopted, they did not use the appropriate method of assignment concealment. The most common defect was the lack of blinded therapists and blinded subjects, but this situation cannot be considered as a defect because it was difficult to implement in the study, and all the studies used blinded assessors. The highest score among the included studies was 9, which was for the only study that blinded the participants [14]. Most studies did not use intention-to-treat analysis because they cancelled the dropout data in the last results. In other items on a PEDro scale, the studies showed high methodological quality, including similarity between groups at baseline, less than 15% dropouts, between-group statistical comparisons, and point measures and variability data.
Table 3.
PEDro scale of methodological quality assessment for the studies.
| First author | Eligibility criteria | Random allocation | Concealed allocation | Similar at baseline | Subjects blinded | Therapists blinded | Assessors blinded | <15% dropouts | Intention-to-treat analysis | Between-group comparisons | Point measures and variability data | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| De Groef [14] | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 9 |
| Listing [15] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 6 |
| Rangon [24] | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
| Wyatt [13] | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
| Tsay [26] | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
| Beurskens [25] | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
| Wilkie [27] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 6 |
| Collinge [29] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 7 |
| Wilkinson [28] | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
| Pyszora [30] | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 7 |
| Arienti [31] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 6 |
| Qian [32] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 6 |
| Chen [33] | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 6 |
PEDro: physiotherapy evidence database. Criteria (2–11) were used to calculate the total PEDro score. Each criterion was scored as either 1 or 0 according to whether the criteria was met or not, respectively.
3.3. Quantitative Data Synthesis
Pain is the primary outcome to be analyzed, and we further analyzed the subgroups according to the different intervention methods of the CG. In addition, we also studied the effects of MT on other cancer-related side effects mentioned in RCTs included.
3.3.1. The Effects of MT on Cancer Pain
(1) MT versus Standard Care. As shown in Figure 2, 7 (54%) studies [13, 15, 26, 27, 30, 32, 33] took standard care as the CG to observe the effects of MT on cancer pain. In these RCTs, only one study [27] showed that there was no significant difference between the EG and CG. Our analysis demonstrated that, compared with standard care, MT can significantly relieve the pain of patients with cancer (n = 592, SMD, 0.63; 95% CI [0.18, 1.08]; P=0.006 < 0.01). From the existing evidence, acupressure may have a good effect on cancer pain. Chen et al. [33] and Qian et al. [32] significantly reduced pain after pressing on acupoints related to symptoms.
Figure 2.
Forest plot of the effects of manual therapy on cancer pain.
(2) MT plus AT versus AT. In Figure 2, 4 (31%) RCTs [14, 24, 25, 31] observed whether the addition of MT would increase the efficacy of AT alone. One study [31] suggested that MT combined with passive mobility, active exercises, and walk could not significantly increase the efficacy. However, through integrating the results of 4 studies, we believed that the effects of MT plus AT can be significantly different from AT alone (n = 123, SMD, 0.79; 95% CI [0.28, 1.30]; P=0.002 < 0.01).
(3) MT versus AT. In Figure 2, the last 2 (15%) studies compared the effects of MT alone and AT on cancer pain. In one study, 288 patients were observed, and it was found that the effects of MT were worse than psychological support, although there was no statistical difference. Another study with a smaller sample size [29] suggested that MT was more effective in relieving pain than reading therapy. Through comprehensive analysis, we believed that the existing evidence cannot demonstrate the efficacy of MT is better than AT alone (n = 385, SMD, −0.24; 95% CI [−1.09, 0.62]; P=0.53 > 0.05).
3.3.2. The Effects of MT on Other Related Symptoms
(1) Fatigue. As shown in Figure 3, fatigue, another major physical symptom related to cancer besides pain, was proved in 3 studies [13, 28, 29] that there was no significant difference between the EG and CG on relieving symptom. Pyszora et al. [30] suggested that compared with standard care, MT can significantly improve the fatigue symptom of patients, which was different from other RCTs. In addition, one study [15] which was not included in the analysis due to the lack of definite data indicated that the results were also in favor of EG but did not reach statistical significance. Therefore, we cannot support statistically that MT intervention can have a better effect (n = 636, SMD, 0.77; 95% CI [−0.09, 1.63]; P=0.08 > 0.05), although MT may have a positive result from the clinical evidence.
Figure 3.
Forest plot of the effects of manual therapy on other related symptoms.
(2) Nausea. In Figure 3, 3 studies [28–30] observed the improvement of MT on nausea. Only one study [29] reported that MT could improve symptoms statistically better than reading therapy. In another study [30], the intervention of MT was less effective than standard care, although the difference was not statistically significant. Therefore, based on the existing evidence, we can only consider that MT intervention may have a weak advantage in nausea (n = 445, SMD, 0.24; 95% CI [−0.00, 0.48]; P=0.05).
(3) Anxiety. In Figure 3, one study [32] suggested that MT can significantly improve the anxiety of cancer patients. However, in most (80%) studies [26, 28–30], although MT may relieve anxiety, the difference was not statistically significant. Therefore, the above evidence cannot support that MT had a good effect on anxiety (n = 641, SMD, 0.76; 95% CI [−0.32, 1.84]; P=0.17 > 0.05).
(4) Depression. In Figure 3, it was demonstrated that MT had no effect on depression (n = 772, SMD, 0.67; 95% CI [−0.28, 1.62]; P=0.17 > 0.05), although all the studies reported that MT intervention may have a positive effect on symptoms. Only Qian et al. [32] demonstrated that acupressure could significantly relieve depression of patients compared with standard care.
(5) Global Well-Being. In Figure 3, 3 studies [27, 28, 30] suggested that MT could improve global well-being compared with the CG, although 2 of them [27, 28] did not have statistical difference. However, in the study of Pyszora et al. [30], the researchers achieved significant effects through MT intervention. In addition, another study [31] added MT on the basis of exercise therapy, making the curative effect worse, although the difference was not statistically significant. Therefore, our evidence supported that MT intervention can increase the global well-being of cancer patients (n = 400, SMD, 0.50; 95% CI [0.02, 0.98]; P=0.04 < 0.05).
3.3.3. The Effects of MT on Physical Function
As shown in Figure 4, the effects of MT on the recovery of physical function were observed in 3 studies [13, 14, 25]. Although the results of De Groef et al. [14] supported the positive effects of MT, there was no statistical difference. Wyatt et al. [13] studied the effects of foot reflexology on physical function, demonstrated that MT can improve the function, while standard care can reduce the original function, and the difference was statistically significant. In another study, Beurskens et al. [25] added massage to home exercise, which significantly improved the efficacy. Therefore, our evidence supported that MT got better effect in improving physical function (n = 271, SMD, 0.35; 95% CI [‒0.04, 0.74]; P=0.04 < 0.05).
Figure 4.
Forest plot of the effects of manual therapy on physical function.
3.3.4. The Follow-Up Effects of MT
As shown in Figure 5, our study was the first time to analyze the follow-up effects of MT. During the follow-up, the main observation was pain and physical function, and the time was 6 weeks to 3 months. The changes of pain after the end of intervention were observed in four studies [13–15, 25]. The results suggested that the effects of MT on cancer pain were still beneficial in the follow-up, although the results of 2 studies [13, 14] were not statistically significant. In the study of Listing et al. [15], standard care alone exacerbated pain during follow-up, while MT significantly improved the situation. Therefore, current evidence demonstrated that MT had a significant effect on pain relief even after a period of time after treatment (n = 330, SMD, 0.52; 95% CI [0.03, 1.01]; P=0.04 < 0.05).
Figure 5.
Forest plot of the follow-up effects of manual therapy.
The follow-up effects of MT on physical function were studied in 3 studies [13, 14, 25]. MT had a positive effect on functional recovery, but the result of one study [14] was not statistically significant. In the other 2 studies [13, 25], MT had significantly improved the function in the evaluation after the intervention, and the improvement was maintained until the follow-up. Therefore, based on the above research studies, we can consider that MT was conducive to the future recovery of physical function, and the results were statistically significant (n = 268, SMD, 0.28; 95% CI [0.02, 0.53]; P=0.03 < 0.05).
3.3.5. Risk of Bias
In Figure 6, no obvious asymmetric distribution of the trials was observed in a funnel plot, but the possibility of publication bias cannot be ruled out. The small sample size may be a major reason for this possible bias.
Figure 6.
Funnel plot of the risk of bias.
4. Discussion
The meta-analysis included 13 RCTs with 1100 patients, to provide an updated synthesis of the current evidence for the effects of MT on cancer pain and fill some research gaps remained to be addressed in the past. We not only brought into more studies and pay attention to follow-up after intervention, but also searched Chinese RCTs, which were not analyzed in the past.
4.1. Analysis of Research Results
Consistent with results of a few systematic reviews and meta-analyses in the past [34, 35], evidence was found of an association between MT and reduction in pain, especially when compared with standard care or MT is added on the basis of AT. However, more previous studies supported that MT had no beneficial effects on cancer pain relief. In the Cochrane Database of Systematic Reviews, Shin et al. [36] held the view that there was a lack of evidence for effectiveness of massage on symptom relief of cancer, and most studies were unreliable and did not report key outcomes. In addition, Boyd et al. [12] and Pan et al. [37] suggested that the evidence was not enough to demonstrate that massage can reduce cancer pain compared to no treatment or sham control. There were also a few studies suggested the seemingly promising results should be interpreted with caution because of limitations [11].
Based on the discussion of pain, we further analyzed the other cancer-related side effects involved in RCTs included, which are often accompanied by pain. In other symptoms, the effects of MT were mainly reflected in improving global well-being, which was never been mentioned before. Consistent with the results of previous studies [36, 37], MT showed no significant difference compared with the CG in anxiety and depression, but we found that MT had a weak advantage in relieving nausea. In addition, fatigue, which was supported to be improved by MT in previous studies [36], did not reflex beneficial effect in our study, but it was reported positive results in most RCTs [15, 28–30].
We believed that the above differences were mainly due to the following reasons. First of all, this study analyzed massage, osteology, chiropractic, acupressure, reflexology, trigger point therapy, and any other physical therapy operated only by hands as MT, instead of studying them separately as in the past [9, 11], because it was impossible to completely separate them in practical application. Secondly, we included a part of Chinese RCTs [32, 33], although few Chinese studies in this field were of high quality. In addition, we did not include crossover design experiments because it may affect the final results, especially when we need to consider follow-up results. Finally, studies that did not involve pain were not included in the analysis of MT on other related symptoms, because pain relief was the main purpose of this study.
The current review, to our knowledge, was the first to evaluate the follow-up effects of MT for cancer pain. According to our results, it can be demonstrated that MT could significantly reduce cancer pain and improve physical function at the end of the intervention, and the significant effects can even last until the follow-up. Therefore, the intervention of MT not only had immediate and sustained analgesic effect but also brought great benefits for the future physical function recovery.
In addition, QoL is a frequent outcome in the RCTs, which we mentioned in Table 3. However, the results of QoL cannot be analyzed comprehensively because there was no unified standard for it. De Groef et al. [14] took QoL as a comprehensive index to evaluate physical function and mental function, and we made another analysis on the former. In the study of Listing et al. [15], QoL was divided into breast symptoms and arm symptoms, and the former was significantly improved after MT intervention. Rangon et al. [24] and Wyatt et al. [13] used FACT-B scale to evaluate QoL, so their research perspective was similar. European Organization of Research and Treatment of Cancer QoL Questionnaire (EORTC QLQ) was also applied to access QoL, but researchers chose different subprojects according to different research purposes [28, 31]. Beurskens et al. [25] used Sickness Impact Profile (SIP) to evaluate the physical disability of patients to demonstrate the significant improvement of QoL. In addition, Collinge and his colleagues [29] used the simple NRS with pain, fatigue, depression, and nausea as the subprojects of QoL, which were analyzed in our study. Therefore, the direct analysis of QoL in the past research was worth further discussion [38].
4.2. Limitations of the Review
There were several limitations in our study. First of all, substantial heterogeneity was observed which mainly owed to the application of different kinds of measurement methods. As our primary outcome measure, pain was evaluated by VAS or NRS in 9 (69%) studies [14, 24–27, 29, 31–33]. The two scales were similar because they measured pain on a score of 1 to 10, and the higher the score, the more severe the pain. Although the VAS score in some studies [14, 26] was 1–100, it was also converted to the maximum of 10 in our review, which did not affect the final result. However, some special scales were used in other research studies. In the study of Listing et al. [15], Short Form-8 Health (SF-8) survey was applied to evaluate pain, which contained one item for each of the eight concepts of the SF-36, and the pain of patients decreased with increasing scores. Other scales were not described in details here, but obviously different measurement methods were the main reason for high heterogeneity. Cancer, on the other hand, is so complex that various measures may describe different dimensions of symptoms, and pain types and treatments can also affect outcomes. In addition, although we thought it was difficult to distinguish different MT methods completely, the difference of MT technology, frequency, duration, and treatment courses may affect the heterogeneity. Therefore, more studies were needed to fully assess how these factors play a role in heterogeneity.
Secondly, the RCTs we included may have possible selection bias. The results did not change when we restricted the analysis to the methodological quality through the PEDro scale. Almost in all studies, both performance and response biases were possible since the lack of blinded therapists and blinded subjects, which were hard to avoid in practical treatment. However, the small sample size and low methodological quality of some of the included studies was worthy of our attention. In addition, although our funnel plot did not show obvious asymmetric distribution, it is difficult to interpret the results of publication bias due to such a small subset of studies. Thus, larger sample sizes and carefully planned designs are required for future analysis, as well as better monitoring of selected parameters.
Finally, the analysis of cancer-related side effects in this study was based on patients suffering from pain. Because pain was our primary outcome measure, a large number of RCTs that did not involve pain were not included in our study, which meant that many studies on fatigue, depression, anxiety, and other symptoms were ignored. On one hand, we mainly focused on cancer pain, so other studies that had nothing to do with pain were excluded; on the other hand, almost all studies of cancer pain involved other accompanying symptoms, which we cannot ignore. Moreover, there were few studies involving each symptom, because of many kinds of other cancer-related symptoms in different RCTs, which may have an impact on the results. In addition, only a few RCTs including follow-up studies were found, and the follow-up results in which were often similar to those after the intervention. Therefore, the current evidence only demonstrated that MT could improve cancer-related side effects on the basis of reducing cancer pain, but whether MT had long-term effects needed further study.
5. Conclusion
The current evidence demonstrated that MT was an effective intervention, which may have immediate effect on cancer pain and may improve physical function and global well-being. Although MT achieved positive results on fatigue, nausea, anxiety, and depression, the current evidence cannot support the effectiveness. In the view of follow-up effects, MT had good effects for the reduction of pain and the recovery of physical function. However, because of limitations, the seemingly promising results should be interpreted with caution.
It was necessary to establish relevant standards for the intervention of MT on cancer pain, such as frequency, duration, and course of treatment, to ensure the normalization of treatment. In addition, for some important outcome indicators, it was better to use a unified measurement method and added special scales if necessary.
Acknowledgments
The authors thank all the participants and researchers involved in the studies cited in our review. This work was supported by the National Natural Science Foundation of China (no. 82030121, 81973973, and 82004493), the Three-Year Action Plan for Further Speed Up the Development of Chinese Medicine in Shanghai (ZY (2018–2020)-CCCX-2004-02), and the Graduate Student Innovation Ability Project of Shanghai University of Traditional Chinese Medicine (no. Y2020017).
Contributor Information
Lingjun Kong, Email: chunyong01@163.com.
Min Fang, Email: fm-tn0510@shutcm.edu.cn.
Data Availability
The data used to support the findings of this study are available from public databases, and more details also can be obtained from the corresponding author on request. He can be reached at fm-tn0510@shutcm.edu.cn.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
Authors' Contributions
Chongjie Yao and Yanbin Cheng contributed equally to this work.
References
- 1.Bray F., Ferlay J., Soerjomataram I., Siegel R. L., Torre L. A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018;68(6):394–424. doi: 10.3322/caac.21492. [DOI] [PubMed] [Google Scholar]
- 2.Neufeld N. J., Elnahal S. M., Alvarez R. H. Cancer pain: a review of epidemiology, clinical quality and value impact. Future Oncology. 2017;13(9):833–841. doi: 10.2217/fon-2016-0423. [DOI] [PubMed] [Google Scholar]
- 3.Li Z., Aninditha T., Griene B., et al. Burden of cancer pain in developing countries: a narrative literature review. ClinicoEconomics and Outcomes Research. 2018;10:675–691. doi: 10.2147/ceor.s181192. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Carlson C. Effectiveness of the World Health Organization cancer pain relief guidelines: an integrative review. Journal of Pain Research. 2016;9:515–534. doi: 10.2147/jpr.s97759. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Jho H. J., Kim Y., Kong K. A., et al. Knowledge, practices, and perceived barriers regarding cancer pain management among physicians and nurses in korea: a nationwide multicenter survey. PLoS One. 2014;9(8) doi: 10.1371/journal.pone.0105900. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Bakshi S., Jain P., Kannan S. An assessment of basic pain knowledge and impact of pain education on Indian Anaesthesiologists - a pre and post questionnaire study. Indian Journal of Anaesthesia. 2014;58(2):127–131. doi: 10.4103/0019-5049.130805. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Chen L., Michalsen A. Management of chronic pain using complementary and integrative medicine. BMJ. 2017;357 doi: 10.1136/bmj.j1284.j1284 [DOI] [PubMed] [Google Scholar]
- 8.Swarm R. A., Paice J. A., Anghelescu D. L., et al. Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2019;17(8):977–1007. doi: 10.6004/jnccn.2019.0038. [DOI] [PubMed] [Google Scholar]
- 9.Lee S.-H., Kim J.-Y., Yeo S., Kim S.-H., Lim S. Meta-analysis of massage therapy on cancer pain. Integrative Cancer Therapies. 2015;14(4):297–304. doi: 10.1177/1534735415572885. [DOI] [PubMed] [Google Scholar]
- 10.Ernst E. Massage therapy for cancer palliation and supportive care: a systematic review of randomised clinical trials. Supportive Care in Cancer. 2009;17(4):333–337. doi: 10.1007/s00520-008-0569-z. [DOI] [PubMed] [Google Scholar]
- 11.Lee P. L. T., Tam K.-W., Yeh M.-L., Wu W.-W. Acupoint stimulation, massage therapy and expressive writing for breast cancer: a systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine. 2016;27:87–101. doi: 10.1016/j.ctim.2016.06.003. [DOI] [PubMed] [Google Scholar]
- 12.Boyd C., Crawford C., Paat C. F., Price A., Xenakis L., Zhang W. The impact of massage therapy on function in pain populations-A systematic review and meta-analysis of randomized controlled trials: Part II, cancer pain populations. Pain Medicine. 2016;17(8):1553–1568. doi: 10.1093/pm/pnw100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wyatt G., Sikorskii A., Rahbar M. H., Victorson D., You M. Health-related quality-of-life outcomes: a reflexology trial with patients with advanced-stage breast cancer. Oncology Nursing Forum. 2012;39(6):568–577. doi: 10.1188/12.onf.568-577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.De Groef A., Van Kampen M., Vervloesem N., et al. Effect of myofascial techniques for treatment of persistent arm pain after breast cancer treatment: randomized controlled trial. Clinical Rehabilitation. 2018;32(4):451–461. doi: 10.1177/0269215517730863. [DOI] [PubMed] [Google Scholar]
- 15.Listing M., Reißhauer A., Krohn M., et al. Massage therapy reduces physical discomfort and improves mood disturbances in women with breast cancer. Psycho-Oncology. 2009;18(12):1290–1299. doi: 10.1002/pon.1508. [DOI] [PubMed] [Google Scholar]
- 16.Tang S., Qian X., Zhang Y., Liu Y. Treating low back pain resulted from lumbar degenerative instability using Chinese Tuina combined with core stability exercises: a randomized controlled trial. Complementary Therapies in Medicine. 2016;25:45–50. doi: 10.1016/j.ctim.2016.01.001. [DOI] [PubMed] [Google Scholar]
- 17.Kong L. J., Zhan H. S., Cheng Y. W., Yuan W. A., Chen B., Fang M. Massage therapy for neck and shoulder pain: a systematic review and meta-analysis. Evidence-Based Complementary and Alternative Medicine. 2013;2013 doi: 10.1155/2013/613279.613278 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Yamato T. P., Maher C., Koes B., Moseley A. The PEDro scale had acceptably high convergent validity, construct validity, and interrater reliability in evaluating methodological quality of pharmaceutical trials. Journal of Clinical Epidemiology. 2017;86:176–181. doi: 10.1016/j.jclinepi.2017.03.002. [DOI] [PubMed] [Google Scholar]
- 19.Moseley A. M., Elkins M. R., Van Der Wees P. J., Pinheiro M. B. Using research to guide practice: the physiotherapy evidence database (PEDro) Brazilian Journal of Physical Therapy. 2019;S1413-3555(1419):30914–30911. doi: 10.1016/j.bjpt.2019.11.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Khiewkhern S., Promthet S., Sukprasert A., Eunhpinitpong W., Bradshaw P. Effectiveness of aromatherapy with light Thai massage for cellular immunity improvement in colorectal cancer patients receiving chemotherapy. Asian Pacific Journal of Cancer Prevention. 2013;14(6):3903–3907. doi: 10.7314/apjcp.2013.14.6.3903. [DOI] [PubMed] [Google Scholar]
- 21.Pfister D. G., Cassileth B. R., Deng G. E., et al. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. Journal of Clinical Oncology. 2010;28(15):2565–2570. doi: 10.1200/jco.2009.26.9860. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Toth M., Marcantonio E. R., Davis R. B., Walton T., Kahn J. R., Phillips R. S. Massage therapy for patients with metastatic cancer: a pilot randomized controlled trial. The Journal of Alternative and Complementary Medicine. 2013;19(7):650–656. doi: 10.1089/acm.2012.0466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Dion L. J., Engen D. J., Lemaine V., et al. Massage therapy alone and in combination with meditation for breast cancer patients undergoing autologous tissue reconstruction: a randomized pilot study. Complementary Therapies in Clinical Practice. 2016;23:82–87. doi: 10.1016/j.ctcp.2015.04.005. [DOI] [PubMed] [Google Scholar]
- 24.Rangon F. B., Koga Ferreira V. T., Rezende M. S., Apolinário A., Ferro A. P., Guirro E. C. D. O. Ischemic compression and kinesiotherapy on chronic myofascial pain in breast cancer survivors. Journal of Bodywork and Movement Therapies. 2018;22(1):69–75. doi: 10.1016/j.jbmt.2017.04.005. [DOI] [PubMed] [Google Scholar]
- 25.Beurskens C. H., Van Uden C. J., Strobbe L. J., Oostendorp R. A., Wobbes T. The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study. BMC Cancer. 2007;7:p. 166. doi: 10.1186/1471-2407-7-166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Tsay S.-L., Chen H.-L., Chen S.-C., Lin H.-R., Lin K.-C. Effects of reflexotherapy on acute postoperative pain and anxiety among patients with digestive cancer. Cancer Nursing. 2008;31(2):109–115. doi: 10.1097/01.ncc.0000305694.74754.7b. [DOI] [PubMed] [Google Scholar]
- 27.Wilkie D., Kampbell J., Cutshall S., et al. Effects of massage on pain intensity, analgesics and quality of life in patients with cancer pain: Hospice Journal, The. 2000;15(3):31–53. doi: 10.1080/0742-969x.2000.11882956. [DOI] [PubMed] [Google Scholar]
- 28.Wilkinson S. M., Love S. B., Westcombe A. M., et al. Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicenter randomized controlled trial. Journal of Clinical Oncology. 2007;25(5):532–539. doi: 10.1200/jco.2006.08.9987. [DOI] [PubMed] [Google Scholar]
- 29.Collinge W., Kahn J., Walton T., et al. Touch, Caring, and Cancer: randomized controlled trial of a multimedia caregiver education program. Supportive Care in Cancer. 2013;21(5):1405–1414. doi: 10.1007/s00520-012-1682-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Pyszora A., Budzyński J., Wójcik A., Prokop A., Krajnik M. Physiotherapy programme reduces fatigue in patients with advanced cancer receiving palliative care: randomized controlled trial. Supportive Care in Cancer. 2017;25(9):2899–2908. doi: 10.1007/s00520-017-3742-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Arienti C., Bosisio T., Ratti S., Miglioli R., Negrini S. Osteopathic manipulative treatment effect on pain relief and quality of life in oncology geriatric patients: a nonrandomized controlled clinical trial. Integrative Cancer Therapies. 2018;17(4):1163–1171. doi: 10.1177/1534735418796954. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Qian Y., Chen Y. The effect of aromatherapy on the quality of life and psychology of patients with cancer pain. Dang Dai Hu Shi. 2019;26(12):37–39. [Google Scholar]
- 33.Chen J. Clinical effect of acupoint massage on Neiguan and Zusanli combined with analgesic medication on remission of severe carcinomatous pain in patients with advanced cancer. Shi Yong Lin Chuang Hu Li Xue Dian Zi Za Zhi. 2019;4(32):27–28. [Google Scholar]
- 34.Wilkinson S., Barnes K., Storey L. Massage for symptom relief in patients with cancer: systematic review. Journal of Advanced Nursing. 2008;63(5):430–439. doi: 10.1111/j.1365-2648.2008.04712.x. [DOI] [PubMed] [Google Scholar]
- 35.Tao W.-W., Jiang H., Tao X.-M., Jiang P., Sha L.-Y., Sun X.-C. Effects of acupuncture, Tuina, tai chi, qigong, and traditional Chinese medicine five-element music therapy on symptom management and quality of life for cancer patients: a meta-analysis. Journal of Pain and Symptom Management. 2016;51(4):728–747. doi: 10.1016/j.jpainsymman.2015.11.027. [DOI] [PubMed] [Google Scholar]
- 36.Shin E. S., Seo K. H., Lee S. H., et al. Massage with or without aromatherapy for symptom relief in people with cancer. The Cochrane Database of Systematic Reviews. 2016;6 doi: 10.1002/14651858.CD009873.pub3.CD009873 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Pan Y. Q., Yang K. H., Wang Y. L., Zhang L. P., Liang H. Q. Massage interventions and treatment-related side effects of breast cancer: a systematic review and meta-analysis. International Journal of Clinical Oncology. 2014;19(5):829–841. doi: 10.1007/s10147-013-0635-5. [DOI] [PubMed] [Google Scholar]
- 38.Pinheiro Da Silva F., Moreira G. M., Zomkowski K., Amaral de Noronha M., Flores Sperandio F. Manual therapy as treatment for chronic musculoskeletal pain in female breast cancer survivors: a systematic review and meta-analysis. Journal of Manipulative and Physiological Therapeutics. 2019;42(7):503–513. doi: 10.1016/j.jmpt.2018.12.007. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data used to support the findings of this study are available from public databases, and more details also can be obtained from the corresponding author on request. He can be reached at fm-tn0510@shutcm.edu.cn.